| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
| 09/15/1998 | US5807881 Method for selectively reducing activated leukocyte cell population |
| 09/15/1998 | US5807876 Inosine-5'-monophospate dehydrogenase; viral diseases, cancer, vascular diseases; merimepodib |
| 09/15/1998 | US5807870 Substituted pipecolinic acid derivatives as HIV protease inhibitors |
| 09/15/1998 | US5807862 Therapeutic compounds containing pyrimidinyl moieties |
| 09/15/1998 | US5807841 HIV protease inhibitors useful for the treatment of AIDS |
| 09/15/1998 | US5807826 Semaphorin gene family |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807714 Method of production of antigen-specific glycosylation inhibiting factor |
| 09/15/1998 | US5807709 Secreted proteins and polynucleotides encoding them |
| 09/15/1998 | US5807703 Secreted proteins and polynucleotides encoding them |
| 09/15/1998 | US5807553 Immonogenic oligosaccharide compositions |
| 09/15/1998 | CA2001750C Pyrrolidine derivatives |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | WO1998039363A2 Immunotoxins and methods of inducing immune tolerance |
| 09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | WO1998039284A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | WO1998039034A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 09/11/1998 | WO1998039033A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 09/11/1998 | WO1998039030A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | WO1998039029A2 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 09/11/1998 | WO1998031795A3 Novel human metallothionein |
| 09/11/1998 | WO1998031393A3 Polysaccharide-peptide-conjugates |
| 09/11/1998 | WO1998030584A3 Secreted proteins and polynucleotides encoding them |
| 09/11/1998 | WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 09/11/1998 | WO1998016238A3 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 09/11/1998 | CA2283415A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | CA2283300A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 09/11/1998 | CA2283143A1 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 09/11/1998 | CA2283076A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | CA2281934A1 Use of preparations containing anti-cd44 antibodies for the treatment of certain tumours and for the supression of immune reactions |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0863155A1 Suppression of T-cell proliferation using peptide fragments of myelin basic protein |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862619A1 Pskh-1 ribozymes and uses in disease treatment |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862566A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 09/09/1998 | EP0862557A1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
| 09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
| 09/09/1998 | EP0663828B1 Treating allergic rhinitis and asthma using (-) Cetirizine |
| 09/09/1998 | EP0650498B1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein |
| 09/09/1998 | EP0573527B1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans |
| 09/09/1998 | CN1192779A Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192732A CB2 receptor agonist compounds |
| 09/09/1998 | CN1192693A Therapeutic agent and autoimmune diseases |
| 09/08/1998 | US5804582 Administering immunogenic organic amine salt of n,n'-diacetylcystine |
| 09/08/1998 | US5804571 Administering an s-omega(omega-aminoalkylamino)alkyl dihydrogen phosphorothioate |
| 09/08/1998 | US5804566 Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| 09/08/1998 | US5804559 Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804381 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| 09/08/1998 | US5804201 Immunomodulatory peptides of vespid antigen 5 |
| 09/08/1998 | US5804197 Recombinant canine herpesviruses |
| 09/08/1998 | US5804188 Administering rna polymerase protein |
| 09/03/1998 | WO1998038320A1 Component of bromelain |
| 09/03/1998 | WO1998038319A1 Component of bromelain |
| 09/03/1998 | WO1998038291A1 Component of bromelain |
| 09/03/1998 | WO1998038216A1 Cell surface molecule mediating cell adhesion and signal transmission |
| 09/03/1998 | WO1998038212A2 Chimeric polypeptides containing chemokine domains |
| 09/03/1998 | WO1998038193A1 Method for the preparation of (+)-calanolide a and analogues thereof |
| 09/03/1998 | WO1998038170A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 09/03/1998 | WO1998038167A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037917A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | WO1998037913A1 Lymphocyte activation inhibitors |
| 09/03/1998 | WO1998037912A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method |
| 09/03/1998 | WO1998037900A1 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control |
| 09/03/1998 | WO1998037896A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037875A1 Drug composition |
| 09/03/1998 | WO1998025574A3 Stimulation of an immune response to differentiation antigen stimulated by altered antigen |
| 09/03/1998 | WO1998024910A3 Mutants of streptococcal toxin c and methods of use |
| 09/03/1998 | WO1998016205A3 Stable glassy state powder formulations |
| 09/03/1998 | DE19716892C1 Vector for expressing immunoglobulin-cytokine fusion protein |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282639A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | CA2282631A1 Lymphocyte activation inhibitors |
| 09/03/1998 | CA2282552A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 09/03/1998 | CA2252790A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/02/1998 | EP0861895A2 aroE shikimate 5 dehydrogenase from Staphylococcus Aureus |
| 09/02/1998 | EP0861890A1 LicC polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861889A1 LicD2 polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861665A1 Infectious bursitis vaccine |
| 09/02/1998 | EP0861266A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 09/02/1998 | EP0861243A1 Heterocyclic compounds as bradykinin antagonists |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 09/02/1998 | EP0861087A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0606217B1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 09/02/1998 | CN1192240A Recombinant mistletoe lectin (rML) |